Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Cell Culture market research products provide analysis of the latest trends, developments and market data for this industry. Research information will help you make informed business decisions.

older | 1 | .... | 8 | 9 | (Page 10) | 11 | 12 | .... | 17 | newer

    0 0

    2016 Global Culture Vessels Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Culture Vessels industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Culture Vessels basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Culture Vessels industry; 3.) the North American Culture Vessels industry; 4.) the European Culture Vessels industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    Global Human Albumin Market 2016-2020 About the Human Albumin Market Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period. The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions. Technavio’s analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from

    0 0

    3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021 The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, application, end user, and region. The scaffold-based segment is expected to register the highest growth rate in the 3D cell culture market, by technology, during the forecast period. The high growth in this segment is attributed to the variety of material and structural choices for scaffold, due to which they are most preferred in various applications. Based on end users, the 3D cell culture market is segmented into research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The biotechnology & pharmaceutical industries segment is expected to account for the largest share of the market in 2016. Increasing prevalence of cancer cases and the need for development of advanced drugs and therapies will drive the growth of this market. Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific,

    0 0

    Global Cell Culture Protein Surface Coating Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022 The global cell culture protein surface coating market is expected to reach $781 million by 2022 growing at 15.4% CAGR during 2016-2022. In regional outlook, market is divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global cell culture protein surface coating market. The major reason of this dominance is the presence of major market players such as Becton, Dickson and Company etc., which are headquartered in North American region. Apart from this, large scale R&D in stem cells, increasing healthcare expenditure and advancements in technology related to biotechnology is also improving the North American market. Asia Pacific is showing fastest growth in the global cell culture protein surface coating market in the forecast year. Rising population, increase in quality of infrastructure in the area of biotechnology and healthcare is the major reason for the growth of Asia Pacific region. Europe is showing rapid growth rate majorly due to favorable government policies, and rising application of biotechnology in the region. Rest of the world is also showing positive growth rate, due to penetration of major players of

    0 0

    2016 Global Biochemicals Control Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biochemicals Control industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Biochemicals Control basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Biochemicals Control industry; 3.) the North American Biochemicals Control industry; 4.) the European Biochemicals Control industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    About the Recombinant Human Erythropoietin (rhEPO) Market in China Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein responsible for producing erythrocytes in the body. In the fetal stage, this protein is produced in the liver; it is secreted by the kidneys in adulthood. During anemic conditions, the body produces an excess of EPO, maintaining the normal levels of red blood cells (RBC). When the endogenous production of EPO is disturbed because of diseases or the use of medications, the normal RBC levels can be maintained by an external supply of EPO-stimulating agents (ESAs). These agents are similar to the natural EPO in structure and function and are administered as injections. They can be produced by recombinant DNA technology and are used to treat anemia due to kidney diseases, cancer, HIV, injuries, or neural diseases. Technavio’s analysts forecast the recombinant human erythropoietin (rhEPO) market in China to grow at a CAGR of 16.89% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the recombinant human erythropoietin (rhEPO) market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded

    0 0

    The Global Cell Culture Consumption Market Report 2016 is a professional and in-depth study on the current state of the Cell Culture Media market The report provides a basic overview of the Cell Culture industry including definitions, classifications, applications and industry chain structure. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report then analyzes the global Cell Culture market size (volume and value), and the sales segment market is also discussed by product type, applications and region. The major Cell Culture market (including USA, Europe, RoW, Asia, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and applications. Then we forecast the 2016-2021 market size of Cell Culture. The report focuses on global major leading brand providing information such as company profiles, sales, sales revenue, market share and contact information. Then Cell Culture production market status is discussed. Finally the marketing, feasibility of new investment projects are assessed and overall research conclusions offered. With 194 tables and figures the report provides key statistics on the state of the industry and is a valuable source

    0 0

    High Throughput Screening (HTS) Market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021) The HTS market accounted for a value of USD XX million in 2015 and is expected to reach USD XX million in 2016. The market is expected to reach USD XX million by 2021, growing at a CAGR of X% during the forecast period of 2016 to 2021. The global high-throughput screening market is mainly driven by target identification & validation, efficacy & safety screening, and monitoring of cell-based activity. High throughput screening (HTS) is a popular approach to target validation as it allows the assaying of a large number of potential biological modulators against a chosen set of defined targets. In this report we provide detail idea about the market, market drivers, restraining factors and opportunity. The analysed impact of drivers and restrains on the future market. We provide information about market segmentation on the basis of its application, equipment and geography, market share analysis and the major players in the market. Key Deliverables: Market analysis for the High throughput screening, with region specific assessments and competition analysis on global and regional scales. Market definition along with drivers, restraint and opportunities. Extensively researched competitive landscape

    0 0

    2016 Global Bioreactor Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Bioreactor industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Bioreactor basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Bioreactor industry; 3.) the North American Bioreactor industry; 4.) the European Bioreactor industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    2016 Global Cell Separation Technologies Report is a professional and in-depth research report on the world's major regional market conditions of the Cell Separation Technologies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cell Separation Technologies basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis,investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Cell Separation Technologies industry; 3.) the North American Cell Separation Technologies industry; 4.) the European Cell Separation Technologies industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    3D Cell Culture Market Analysis By Technology (Scaffold Based, Hydrogels, Polymeric Scaffolds, Micro-patterned Surface Microplates Scaffold Free, Hanging Drop Microplates, Spheroid Microplates with ULA coating, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting, Bioreactors), By Application, (Cancer, Tissue Engineering & Immunohistochemistry, Drug Development, Stem Cell Research, Cell to Cell Interactions, Transfection), By End Use And Segment Forecasts To 2024 The global 3D cell culture market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of animal models for histological analysis and biochemical assays is expected to fuel demand for 3D cell culture products thus driving growth in the coming years. Advent of technology with respect to spheroid formation and matured assay methods, is expected to boost the emergence of 3D optimized assays, kits, and protocols, in turn, expediting the entire research process. In addition, the scope of three-dimensional (3D) cell culturing experiments for evaluation of drug moiety is anticipated to grow owing to advantages associated with its usage. These advantages include increased cell to extra cellular matrix (ECM) as well as intercellular interactions, variation in the proliferation zones, ease for analyzing

    0 0

    The ' Global and Chinese Albumin Industry, 2011-2021 Market Research Report ' is a professional and in-depth study on the current state of the global Albumin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Albumin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2011-2016 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Albumin industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2016-2021 market development trends of Albumin industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Albumin Industry before evaluating

    0 0

    Global Cell and Tissue Technologies Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 – 2022 The global cell and tissue technology market is expected to grow at the CAGR of 6.56% during 2016-2022. The market has generated revenue more than $19 billion in 2016 and is projected to reach up to $30 billion by 2022. Due to increasing chronic cases and inferior’s diseases, increasing health industry, increasing advanced technology products and increasing government and private funding for cell based research act as the major factors which increase the market of cell and tissue technology globally. The key drivers which accelerate the market are rising cancer cases. According to World Health Organization, the cancer rate is increasing to reach to 15 million new cases by 2020. According to WHO report, more than 1.2 million new cases are diagnosed for lung cancer worldwide, one million new cases of breast, 870000 cases of stomach, 560000 cases of cervical, 410000 cases of head and neck cancer and many more. Due to these cases, the demand of cell and tissue technology has increased. The cell and tissue technology is segmented on the basis of product, process and end users. On the basis

    0 0

    Global Cell Analysis Market 2016-2020 About Cell Analysis Cell analysis helps identify and map many of the basic biochemical and physical processes of life. Bio-specimen preparation, cell and tissue separation, and characterization products are used to isolate and assess cells. Cell analysis products are used by various industries including biotechnology, pharmaceutical, research, and contract research organizations (CROs). They have a wide range of applications in drug discovery and development, stem cell research, cell biology, and other research practices. These technologies help analyze the internal structure of cells, their characteristics, cellular pathways, and the cellular response to any component such as a drug. Technavio’s analysts forecast the global cell analysis market to grow at a CAGR of 7.08% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global cell analysis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of the instruments, and consumables. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Cell Analysis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its

    0 0

    2016 Global Cell Culture Media Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cell Culture Media industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cell Culture Media basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Cell Culture Media industry; 3.) the North American Cell Culture Media industry; 4.) the European Cell Culture Media industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    This report studies Cell Isolation/Cell Separation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering BD Bioscience Beckman Coulter Ge Healthcare merck Millipore miltenyi Biotec Pluriselect Life Science Sigma-Aldrich Corporation Stemcell Technologies Terumo BCT Thermo Fisher ScientificCompany 13 market Segment by Regions, this report splits Global into several key Regions, with consumption, revenue, market share and growth rate of Cell Isolation/Cell Separation in these regions, from 2011 to 2021 (forecast), like USA Europe China Japan Row Split by Product Types, like Reagent Instrument Others Split by applications, like Hospital Biotechnology Research Center Others

    0 0

    Cell-Based Assays World Industry and Market Prospects 2016-2026 Cell assaying for pharma – prospects for technologies shaping that medical testing Visiongain’s new report, Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research, examines those companies, trends, products, services and technologies. It investigates how those forces will shape that bioassays industry over the next ten years. To support that analysis with data, our study shows revenue forecasts at overall world, submarket and national level. Its purpose is to help companies and other organisations understand the potential of that cellular testing for medicine. Use of cell lines in bioassays becomes more important in drug discovery and development. The cost of developing a new drug is now estimated to be around $2.6bn. Set against that background of rising costs, cell-based assays have become a vital tool for drug discovery, development and basic research. Those assays provide many advantages over traditional biochemical assays and animal models, and are continuing to improve owing to advances in high-throughput screening (HTS) technology, automation and miniaturisation. Cell-based assays can provide a more-accurate representation of human in vivo conditions; they are reliable and, most important for drug development companies, they have high

    0 0

    Single-use Bioprocessing Market by Product (Single-use Media Bags and Containers, Single-use Bioreactor, Filtration Assemblies), Application (Cell Culture, Purification), End User (Life Science R&D, Biopharmaceutical Manufacturer) - Global Forecast to 2021 Rising Biopharmaceutical Demand and Increasing Investments in R&D Activities Drive Growth of the Single-use Bioprocessing Market The global single-use bioprocessing market is projected to reach USD 5.44 billion by 2021 from USD 2.47 billion in 2016, at a CAGR of 17.8% from 2016 to 2021. Developing markets such as the Brazil, China, and India are lucrative markets for single-use bioprocessing, owing to increasing investment in R&D activities by biopharmaceutical manufacturers. The report segments the global single-use bioprocessing market by product, application, end user, and region. The single-use bioreactors segment is expected to grow at the highest CAGR in the forecast period. Media bags and containers are the key playing field in the single-use bioprocessing product market, owing to increasing adoption of single use media bags and containers in storage and transportation application. On the basis of applications, the single-use bioprocessing market is categorized into filtration, storage, cell culture, mixing, and purification. Filtration application segment is expected to be the new revenue pocket in the application market. Increasing adoption

    0 0

    The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or the flu, is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season. Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has resulted in the lucrative growth of this segment with the fastest CAGR. Reverse transcription polymerase chain reaction (RT-PCR) holds the second highest market share following RIDTs, and this can be attributed to

    0 0

    2016 Global Cell Culture Media Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cell Culture Media industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cell Culture Media basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Cell Culture Media industry; 3.) the North American Cell Culture Media industry; 4.) the European Cell Culture Media industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

older | 1 | .... | 8 | 9 | (Page 10) | 11 | 12 | .... | 17 | newer